(Q34171761)

31 July 2017

Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells (English)

1 reference

31 July 2017

Charlotte A Jonsson

1

1 reference

PubMed ID

12538032

31 July 2017

Hans Carlsten

series ordinal

2

1 reference

PubMed ID

12538032

31 July 2017

language of work or name

1 reference

1 January 2003

1 reference

International Immunopharmacology

31 July 2017

1 reference

31 July 2017

3

1 reference

31 July 2017

1

1 reference

31 July 2017

31-37

1 reference

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Mycophenolate Mofetil Ameliorates Perivascular T Lymphocyte Inflammation and Reduces the Double-Negative T Cell Population in SLE-Prone MRLlpr/lpr Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

The design and development of an immunosuppressive drug, mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Mycophenolate mofetil and its mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Monoclonal antibodies against rat immunoglobulin kappa chains

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

Inosine monophosphate dehydrogenase inhibitors. Probes for investigations of the functions of guanine nucleotide binding proteins in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900210-2

7 January 2021

10.1016/S1567-5769(02)00210-2

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12538032